| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neuropeptide binding | 4.97e-13 | 37 | 38 | 7 | GO:0042923 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.72e-12 | 133 | 38 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.33e-12 | 140 | 38 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 3.89e-10 | 7 | 38 | 4 | GO:0004985 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADGRG7 NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 GPR157 EDNRB OPRK1 OPRL1 OPRM1 | 4.45e-09 | 884 | 38 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.10e-08 | 53 | 38 | 5 | GO:0008188 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADGRG7 NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 GPR157 TNFRSF8 EDNRB OPRK1 OPRL1 OPRM1 | 8.31e-08 | 1353 | 38 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | peptide binding | 1.22e-07 | 318 | 38 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 3.55e-06 | 55 | 38 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 2.11e-05 | 4 | 38 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 2.11e-05 | 4 | 38 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 2.11e-05 | 4 | 38 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 2.11e-05 | 4 | 38 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | hormone binding | 4.31e-05 | 103 | 38 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 7.36e-05 | 7 | 38 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.39e-05 | 758 | 38 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 9.80e-05 | 8 | 38 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | transporter activity | TMEM184C ABCC11 GJC2 KCNMB4 ABCC4 SLC5A10 CLCN1 CLDN17 SLC5A2 OPRM1 | 1.08e-04 | 1289 | 38 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.26e-04 | 9 | 38 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.57e-04 | 10 | 38 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.92e-04 | 1180 | 38 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.05e-04 | 171 | 38 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.65e-04 | 15 | 38 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 4.71e-04 | 17 | 38 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.03e-03 | 25 | 38 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.03e-03 | 25 | 38 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 1.11e-03 | 26 | 38 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 1.11e-03 | 26 | 38 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.20e-03 | 27 | 38 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.39e-03 | 29 | 38 | 2 | GO:0015216 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.39e-03 | 29 | 38 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.48e-03 | 30 | 38 | 2 | GO:0016417 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 1.79e-03 | 33 | 38 | 2 | GO:0015215 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.90e-03 | 34 | 38 | 2 | GO:0015125 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.90e-03 | 34 | 38 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 2.25e-03 | 37 | 38 | 2 | GO:0016409 | |
| GeneOntologyMolecularFunction | amide binding | 2.44e-03 | 299 | 38 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 2.50e-03 | 39 | 38 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.89e-03 | 42 | 38 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | channel activity | 3.02e-03 | 525 | 38 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.05e-03 | 526 | 38 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.59e-03 | 793 | 38 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.92e-03 | 49 | 38 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.97e-03 | 182 | 38 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.12e-03 | 184 | 38 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 5.64e-03 | 59 | 38 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 6.01e-03 | 61 | 38 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 7.85e-03 | 70 | 38 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 8.51e-03 | 73 | 38 | 2 | GO:0170055 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.04e-02 | 81 | 38 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.10e-02 | 459 | 38 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.15e-02 | 465 | 38 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.17e-02 | 86 | 38 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.25e-02 | 477 | 38 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.27e-02 | 90 | 38 | 2 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.64e-02 | 103 | 38 | 2 | GO:0005253 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.83e-02 | 109 | 38 | 2 | GO:0042626 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.15e-02 | 119 | 38 | 2 | GO:0015294 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 2.12e-09 | 124 | 37 | 7 | GO:0007218 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 6.19e-09 | 13 | 37 | 4 | GO:0038003 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.38e-08 | 286 | 37 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | eating behavior | 5.01e-08 | 56 | 37 | 5 | GO:0042755 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.27e-07 | 133 | 37 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | copulation | 1.49e-07 | 27 | 37 | 4 | GO:0007620 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 2.07e-07 | 74 | 37 | 5 | GO:0019098 | |
| GeneOntologyBiologicalProcess | feeding behavior | 4.07e-07 | 162 | 37 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | positive regulation of penile erection | 4.43e-07 | 9 | 37 | 3 | GO:0060406 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADGRG7 NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 GPR157 EDNRB OPRK1 OPRL1 OPRM1 | 4.50e-07 | 1395 | 37 | 13 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of penile erection | 8.68e-07 | 11 | 37 | 3 | GO:0060405 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.07e-06 | 191 | 37 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | penile erection | 1.16e-06 | 12 | 37 | 3 | GO:0043084 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC11 GJC2 KCNMB4 ABCC4 SLC5A10 CLCN1 CLDN17 EDNRB OPRK1 SLC5A2 OPRM1 | 2.55e-06 | 1115 | 37 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | endocrine process | 2.60e-06 | 123 | 37 | 5 | GO:0050886 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC11 GJC2 KCNMB4 ABCC4 SLC5A10 CLCN1 P2RY1 CLDN17 EDNRB OPRK1 SLC5A2 OPRM1 | 2.82e-06 | 1374 | 37 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | mating behavior | 3.23e-06 | 57 | 37 | 4 | GO:0007617 | |
| GeneOntologyBiologicalProcess | estrous cycle | 5.93e-06 | 20 | 37 | 3 | GO:0044849 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 9.38e-06 | 3 | 37 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | signal release | 1.66e-05 | 653 | 37 | 8 | GO:0023061 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.67e-05 | 86 | 37 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | regulation of urine volume | 2.09e-05 | 30 | 37 | 3 | GO:0035809 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 3.87e-05 | 358 | 37 | 6 | GO:0015850 | |
| GeneOntologyBiologicalProcess | negative regulation of luteinizing hormone secretion | 4.68e-05 | 6 | 37 | 2 | GO:0033685 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 4.68e-05 | 6 | 37 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 4.74e-05 | 224 | 37 | 5 | GO:0007204 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 5.92e-05 | 1017 | 37 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | sperm ejaculation | 6.54e-05 | 7 | 37 | 2 | GO:0042713 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 6.54e-05 | 7 | 37 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.24e-04 | 442 | 37 | 6 | GO:0050878 | |
| GeneOntologyBiologicalProcess | regulation of luteinizing hormone secretion | 1.40e-04 | 10 | 37 | 2 | GO:0033684 | |
| GeneOntologyBiologicalProcess | behavior | 1.49e-04 | 891 | 37 | 8 | GO:0007610 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.59e-04 | 153 | 37 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | negative regulation of gonadotropin secretion | 1.70e-04 | 11 | 37 | 2 | GO:0032277 | |
| GeneOntologyBiologicalProcess | regulation of endocrine process | 1.78e-04 | 61 | 37 | 3 | GO:0044060 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 2.35e-04 | 67 | 37 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | luteinizing hormone secretion | 2.81e-04 | 14 | 37 | 2 | GO:0032275 | |
| GeneOntologyBiologicalProcess | negative regulation of cAMP-mediated signaling | 2.81e-04 | 14 | 37 | 2 | GO:0043951 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.15e-04 | 183 | 37 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | positive regulation of urine volume | 3.24e-04 | 15 | 37 | 2 | GO:0035810 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 3.52e-04 | 344 | 37 | 5 | GO:0003018 | |
| GeneOntologyBiologicalProcess | endocrine hormone secretion | 3.55e-04 | 77 | 37 | 3 | GO:0060986 | |
| GeneOntologyBiologicalProcess | insemination | 3.70e-04 | 16 | 37 | 2 | GO:0007320 | |
| GeneOntologyBiologicalProcess | regulation of gonadotropin secretion | 3.70e-04 | 16 | 37 | 2 | GO:0032276 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 3.83e-04 | 79 | 37 | 3 | GO:0050432 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.58e-04 | 202 | 37 | 4 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.58e-04 | 202 | 37 | 4 | GO:0035296 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.66e-04 | 203 | 37 | 4 | GO:0035150 | |
| GeneOntologyBiologicalProcess | maternal behavior | 4.70e-04 | 18 | 37 | 2 | GO:0042711 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.70e-04 | 18 | 37 | 2 | GO:0106072 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 4.70e-04 | 18 | 37 | 2 | GO:0007194 | |
| GeneOntologyBiologicalProcess | secretion by cell | 4.95e-04 | 1064 | 37 | 8 | GO:0032940 | |
| GeneOntologyBiologicalProcess | positive regulation of catecholamine secretion | 5.25e-04 | 19 | 37 | 2 | GO:0033605 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 5.25e-04 | 19 | 37 | 2 | GO:0031280 | |
| GeneOntologyBiologicalProcess | parental behavior | 6.44e-04 | 21 | 37 | 2 | GO:0060746 | |
| GeneOntologyBiologicalProcess | ovulation cycle | 6.57e-04 | 95 | 37 | 3 | GO:0042698 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 6.77e-04 | 96 | 37 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | gonadotropin secretion | 7.07e-04 | 22 | 37 | 2 | GO:0032274 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 7.07e-04 | 22 | 37 | 2 | GO:0051350 | |
| GeneOntologyBiologicalProcess | renal tubular secretion | 7.74e-04 | 23 | 37 | 2 | GO:0097254 | |
| GeneOntologyBiologicalProcess | export from cell | 8.40e-04 | 1153 | 37 | 8 | GO:0140352 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 8.78e-04 | 105 | 37 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 9.90e-04 | 26 | 37 | 2 | GO:0014061 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 9.90e-04 | 26 | 37 | 2 | GO:0106070 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.06e-03 | 112 | 37 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.11e-03 | 922 | 37 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 1.15e-03 | 28 | 37 | 2 | GO:0048243 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.17e-03 | 116 | 37 | 3 | GO:0015844 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.17e-03 | 931 | 37 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.17e-03 | 931 | 37 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | secretion | 1.22e-03 | 1221 | 37 | 8 | GO:0046903 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 1.23e-03 | 118 | 37 | 3 | GO:2000243 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.23e-03 | 939 | 37 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.25e-03 | 942 | 37 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.26e-03 | 684 | 37 | 6 | GO:0010817 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 1.32e-03 | 121 | 37 | 3 | GO:0042310 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.45e-03 | 125 | 37 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 1.45e-03 | 125 | 37 | 3 | GO:0043279 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.54e-03 | 976 | 37 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | response to estradiol | 1.55e-03 | 128 | 37 | 3 | GO:0032355 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 1.60e-03 | 33 | 37 | 2 | GO:0018345 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.77e-03 | 1000 | 37 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.79e-03 | 733 | 37 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of system process | 1.80e-03 | 734 | 37 | 6 | GO:0044057 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.88e-03 | 740 | 37 | 6 | GO:1903530 | |
| GeneOntologyBiologicalProcess | amine transport | 1.89e-03 | 137 | 37 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | excretion | 2.00e-03 | 37 | 37 | 2 | GO:0007588 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 2.11e-03 | 38 | 37 | 2 | GO:0015874 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.31e-03 | 1048 | 37 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | regulation of cAMP-mediated signaling | 2.34e-03 | 40 | 37 | 2 | GO:0043949 | |
| GeneOntologyBiologicalProcess | renal system process | 2.40e-03 | 149 | 37 | 3 | GO:0003014 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 2.79e-03 | 801 | 37 | 6 | GO:0051046 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 2.82e-03 | 44 | 37 | 2 | GO:0015865 | |
| GeneOntologyBiologicalProcess | renal absorption | 2.95e-03 | 45 | 37 | 2 | GO:0070293 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.22e-03 | 47 | 37 | 2 | GO:0015721 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.41e-05 | 487 | 38 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | apical part of cell | 8.29e-05 | 592 | 38 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 9.06e-05 | 48 | 38 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | cilium | 1.74e-04 | 898 | 38 | 8 | GO:0005929 | |
| GeneOntologyCellularComponent | ciliary transition zone | 4.29e-04 | 81 | 38 | 3 | GO:0035869 | |
| GeneOntologyCellularComponent | non-motile cilium | 4.31e-04 | 196 | 38 | 4 | GO:0097730 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.04e-03 | 431 | 38 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.05e-03 | 139 | 38 | 3 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.69e-03 | 153 | 38 | 3 | GO:0097731 | |
| MousePheno | abnormal chemically-elicited antinociception | 4.52e-07 | 29 | 31 | 4 | MP:0001980 | |
| MousePheno | impaired behavioral response to morphine | 1.17e-06 | 10 | 31 | 3 | MP:0009757 | |
| MousePheno | abnormal behavioral response to morphine | 2.78e-06 | 13 | 31 | 3 | MP:0020159 | |
| MousePheno | decreased chemically-elicited antinociception | 9.34e-06 | 19 | 31 | 3 | MP:0001982 | |
| MousePheno | abnormal pain threshold | 2.26e-05 | 267 | 31 | 6 | MP:0001970 | |
| MousePheno | impaired behavioral response to anesthetic | 4.74e-05 | 5 | 31 | 2 | MP:0009778 | |
| MousePheno | abnormal conditioned place preference behavior | 6.16e-05 | 35 | 31 | 3 | MP:0009711 | |
| MousePheno | abnormal behavioral response to addictive substance | 7.23e-05 | 102 | 31 | 4 | MP:0009748 | |
| MousePheno | impaired behavioral response to addictive substance | 1.32e-04 | 45 | 31 | 3 | MP:0009750 | |
| MousePheno | increased chemically-elicited antinociception | 1.32e-04 | 8 | 31 | 2 | MP:0001981 | |
| MousePheno | abnormal touch/ nociception | 1.52e-04 | 376 | 31 | 6 | MP:0001968 | |
| MousePheno | decreased behavioral withdrawal response | 1.70e-04 | 9 | 31 | 2 | MP:0009776 | |
| MousePheno | abnormal associative learning | 1.93e-04 | 393 | 31 | 6 | MP:0002062 | |
| MousePheno | abnormal gastrointestinal motility | 2.03e-04 | 52 | 31 | 3 | MP:0011082 | |
| MousePheno | enhanced conditioned place preference behavior | 2.12e-04 | 10 | 31 | 2 | MP:0009713 | |
| MousePheno | abnormal learning/memory/conditioning | KIAA1549 GJC2 PRLHR GALR1 CLCN1 OXTR PARP8 OPRK1 OPRL1 OPRM1 | 2.26e-04 | 1239 | 31 | 10 | MP:0002063 |
| MousePheno | abnormal cognition | KIAA1549 GJC2 PRLHR GALR1 CLCN1 OXTR PARP8 OPRK1 OPRL1 OPRM1 | 2.37e-04 | 1246 | 31 | 10 | MP:0014114 |
| MousePheno | abnormal digestive system physiology | 2.74e-04 | 599 | 31 | 7 | MP:0001663 | |
| MousePheno | abnormal behavioral withdrawal response | 3.10e-04 | 12 | 31 | 2 | MP:0009774 | |
| MousePheno | abnormal behavioral response to anesthetic | 3.10e-04 | 12 | 31 | 2 | MP:0009777 | |
| MousePheno | increased circulating insulin level | 3.62e-04 | 283 | 31 | 5 | MP:0002079 | |
| MousePheno | abnormal thermal nociception | 4.92e-04 | 168 | 31 | 4 | MP:0002733 | |
| MousePheno | hypoalgesia | 5.14e-04 | 170 | 31 | 4 | MP:0003043 | |
| MousePheno | abnormal circulating insulin level | 7.35e-04 | 505 | 31 | 6 | MP:0001560 | |
| MousePheno | impaired behavioral response to xenobiotic | 8.05e-04 | 83 | 31 | 3 | MP:0009747 | |
| MousePheno | enhanced fertility | 8.82e-04 | 20 | 31 | 2 | MP:0010143 | |
| MousePheno | increased litter size | 8.82e-04 | 20 | 31 | 2 | MP:0001934 | |
| MousePheno | increased circulating chloride level | 1.26e-03 | 97 | 31 | 3 | MP:0003019 | |
| MousePheno | impaired conditioned place preference behavior | 1.50e-03 | 26 | 31 | 2 | MP:0009712 | |
| Domain | GPCR_Rhodpsn_7TM | NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 GPR157 EDNRB OPRK1 OPRL1 OPRM1 | 4.74e-09 | 670 | 38 | 12 | IPR017452 |
| Domain | Opioid_rcpt | 3.10e-08 | 4 | 38 | 3 | IPR001418 | |
| Domain | 7tm_1 | NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 6.45e-08 | 677 | 38 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 7.26e-08 | 685 | 38 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 7.94e-08 | 691 | 38 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | NPBWR1 PRLHR GALR1 OXTR GPR101 SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 8.05e-08 | 692 | 38 | 11 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | 9.59e-08 | 112 | 38 | 6 | SM01381 | |
| Domain | DUF3827 | 4.03e-06 | 2 | 38 | 2 | IPR024606 | |
| Domain | DUF3827 | 4.03e-06 | 2 | 38 | 2 | PF12877 | |
| Domain | Na/solute_symporter_CS | 1.12e-04 | 8 | 38 | 2 | IPR018212 | |
| Domain | SSF | 2.63e-04 | 12 | 38 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 2.63e-04 | 12 | 38 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.63e-04 | 12 | 38 | 2 | PS50283 | |
| Domain | NA_SOLUT_SYMP_2 | 2.63e-04 | 12 | 38 | 2 | PS00457 | |
| Domain | zf-DHHC | 9.93e-04 | 23 | 38 | 2 | PF01529 | |
| Domain | ABC_membrane | 1.08e-03 | 24 | 38 | 2 | PF00664 | |
| Domain | DHHC | 1.17e-03 | 25 | 38 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 1.17e-03 | 25 | 38 | 2 | IPR001594 | |
| Domain | ABC_TM1F | 1.47e-03 | 28 | 38 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 1.47e-03 | 28 | 38 | 2 | IPR011527 | |
| Domain | ABC_transporter_CS | 3.30e-03 | 42 | 38 | 2 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 4.29e-03 | 48 | 38 | 2 | PS50893 | |
| Domain | ABC_tran | 4.29e-03 | 48 | 38 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 4.46e-03 | 49 | 38 | 2 | PS00211 | |
| Domain | 7tm_2 | 4.64e-03 | 50 | 38 | 2 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.64e-03 | 50 | 38 | 2 | PS00650 | |
| Domain | ABC_transporter-like | 4.64e-03 | 50 | 38 | 2 | IPR003439 | |
| Domain | GPCR_2-like | 6.62e-03 | 60 | 38 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 6.62e-03 | 60 | 38 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 6.84e-03 | 61 | 38 | 2 | PS50261 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.11e-10 | 70 | 33 | 7 | MM15959 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.44e-10 | 260 | 33 | 10 | M39397 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.47e-10 | 75 | 33 | 7 | M39696 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.80e-10 | 272 | 33 | 10 | M13380 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 4.89e-10 | 197 | 33 | 9 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 4.89e-10 | 197 | 33 | 9 | MM14970 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.48e-09 | 330 | 33 | 10 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.70e-09 | 333 | 33 | 10 | MM14963 | |
| Pathway | WP_GPCRS_NONODORANT | 6.88e-09 | 266 | 33 | 9 | MM15843 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.27e-09 | 186 | 33 | 8 | MM15994 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.10e-08 | 430 | 33 | 10 | MM15160 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 6.22e-08 | 463 | 33 | 10 | M507 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DAGLB NPBWR1 PRLHR GALR1 OXTR SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 1.32e-07 | 646 | 33 | 11 | MM14962 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DAGLB NPBWR1 PRLHR GALR1 OXTR SSTR3 P2RY1 EDNRB OPRK1 OPRL1 OPRM1 | 3.06e-07 | 702 | 33 | 11 | M746 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.90e-05 | 289 | 33 | 6 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.76e-05 | 314 | 33 | 6 | M600 | |
| Pathway | WP_GPCRS_ODORANT | 4.71e-04 | 157 | 33 | 4 | MM15872 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 7.94e-04 | 18 | 33 | 2 | M27901 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 8.86e-04 | 19 | 33 | 2 | MM14718 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.09e-03 | 21 | 33 | 2 | M27058 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.40e-03 | 210 | 33 | 4 | MM15043 | |
| Pathway | WP_GPCRS_OTHER | 1.44e-03 | 96 | 33 | 3 | MM15939 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.57e-03 | 217 | 33 | 4 | M18437 | |
| Pubmed | 1.80e-11 | 179 | 38 | 8 | 18577758 | ||
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 4.81e-09 | 4 | 38 | 3 | 8941707 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 11430857 | ||
| Pubmed | 2.86e-08 | 81 | 38 | 5 | 22723691 | ||
| Pubmed | 7.94e-08 | 200 | 38 | 6 | 18240029 | ||
| Pubmed | 1.45e-07 | 43 | 38 | 4 | 23597562 | ||
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 4.34e-07 | 14 | 38 | 3 | 15086532 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23652222 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 7802669 | ||
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 1.16e-06 | 2 | 38 | 2 | 24651466 | |
| Pubmed | κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | 1.16e-06 | 2 | 38 | 2 | 31940240 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15748148 | ||
| Pubmed | Differential involvement of the mu and kappa opioid receptors in spatial learning. | 1.16e-06 | 2 | 38 | 2 | 12884965 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 16530171 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 28512665 | ||
| Pubmed | Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. | 1.16e-06 | 2 | 38 | 2 | 30152845 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27838450 | ||
| Pubmed | Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area. | 1.16e-06 | 2 | 38 | 2 | 28007761 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 34951141 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22138325 | ||
| Pubmed | Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. | 1.16e-06 | 2 | 38 | 2 | 16954126 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12133003 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27958613 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17185983 | ||
| Pubmed | Ligand directed signaling differences between rodent and human κ-opioid receptors. | 1.16e-06 | 2 | 38 | 2 | 23086943 | |
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 2.72e-06 | 25 | 38 | 3 | 28154160 | |
| Pubmed | Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms. | 3.48e-06 | 3 | 38 | 2 | 26946441 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19032295 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 31806881 | ||
| Pubmed | Nociception increases during opioid infusion in opioid receptor triple knock-out mice. | 3.48e-06 | 3 | 38 | 2 | 17544222 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15090050 | ||
| Pubmed | Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | 3.48e-06 | 3 | 38 | 2 | 14745298 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11109025 | ||
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 3.48e-06 | 3 | 38 | 2 | 8114680 | |
| Pubmed | Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. | 3.48e-06 | 3 | 38 | 2 | 22752269 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11032994 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 10082819 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 25855262 | ||
| Pubmed | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. | 3.48e-06 | 3 | 38 | 2 | 18338799 | |
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 3.48e-06 | 3 | 38 | 2 | 18718480 | |
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 3.48e-06 | 3 | 38 | 2 | 18537939 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 23220294 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12603260 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17676326 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24874714 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 38747277 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 26692286 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17374034 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 30365572 | ||
| Pubmed | Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. | 3.48e-06 | 3 | 38 | 2 | 11826143 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18213616 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 33555255 | ||
| Pubmed | Enhanced humoral response in kappa-opioid receptor knockout mice. | 3.48e-06 | 3 | 38 | 2 | 12507774 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 14975676 | ||
| Pubmed | Quantitative trait loci influencing morphine antinociception in four mapping populations. | 3.48e-06 | 3 | 38 | 2 | 11420618 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11504820 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15178356 | ||
| Pubmed | Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 3.48e-06 | 3 | 38 | 2 | 12431223 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 9572309 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 28049031 | ||
| Pubmed | Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. | 3.48e-06 | 3 | 38 | 2 | 11069979 | |
| Pubmed | Formalin-induced pain is reduced in sigma(1) receptor knockout mice. | 3.48e-06 | 3 | 38 | 2 | 15777781 | |
| Pubmed | Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function. | 4.79e-06 | 30 | 38 | 3 | 27568567 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 17997230 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 16053916 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 12413885 | ||
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 6.96e-06 | 4 | 38 | 2 | 9502813 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 30249798 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 26228411 | ||
| Pubmed | Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. | 1.16e-05 | 5 | 38 | 2 | 20534436 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 33782947 | ||
| Pubmed | Variations in opioid receptor genes in neonatal abstinence syndrome. | 1.16e-05 | 5 | 38 | 2 | 26233486 | |
| Pubmed | 1.32e-05 | 132 | 38 | 4 | 26439863 | ||
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 1.74e-05 | 6 | 38 | 2 | 9746745 | |
| Pubmed | Genetic susceptibility to heroin addiction: a candidate gene association study. | 1.74e-05 | 6 | 38 | 2 | 18518925 | |
| Pubmed | Evidence of efficient stop codon readthrough in four mammalian genes. | 1.74e-05 | 6 | 38 | 2 | 25013167 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 12044478 | ||
| Pubmed | 1.84e-05 | 300 | 38 | 5 | 19086053 | ||
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 3.24e-05 | 8 | 38 | 2 | 24855103 | |
| Pubmed | Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs. | 4.16e-05 | 9 | 38 | 2 | 11726686 | |
| Pubmed | Murine chromosomal location of the mu and kappa opioid receptor genes. | 4.16e-05 | 9 | 38 | 2 | 7959748 | |
| Pubmed | Chromosomal localization of opioid peptide and receptor genes in the mouse. | 7.62e-05 | 12 | 38 | 2 | 7752808 | |
| Pubmed | 7.70e-05 | 75 | 38 | 3 | 2834384 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 23840749 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 26053317 | ||
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 23034182 | ||
| Pubmed | 1.56e-04 | 17 | 38 | 2 | 21483469 | ||
| Pubmed | Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon. | 2.65e-04 | 22 | 38 | 2 | 11124115 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 3.74e-04 | 128 | 38 | 3 | 19058789 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 3.91e-04 | 130 | 38 | 3 | 19874574 | |
| Pubmed | Molecular and anatomical characterization of parabrachial neurons and their axonal projections. | 4.63e-04 | 29 | 38 | 2 | 36317965 | |
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 6.38e-04 | 34 | 38 | 2 | 20834067 | |
| Pubmed | 8.83e-04 | 40 | 38 | 2 | 25275127 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 9.25e-04 | 697 | 38 | 5 | 28298427 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.04e-03 | 182 | 38 | 3 | 20468064 | |
| Interaction | GPRASP1 interactions | 6.78e-06 | 67 | 37 | 4 | int:GPRASP1 | |
| Interaction | SLC41A1 interactions | 5.37e-05 | 40 | 37 | 3 | int:SLC41A1 | |
| Interaction | LAT interactions | 6.15e-05 | 117 | 37 | 4 | int:LAT | |
| Interaction | OPRD1 interactions | 1.12e-04 | 51 | 37 | 3 | int:OPRD1 | |
| GeneFamily | Opioid receptors | 2.01e-08 | 4 | 32 | 3 | 245 | |
| GeneFamily | ATP binding cassette subfamily C | 2.34e-04 | 13 | 32 | 2 | 807 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 8.17e-04 | 24 | 32 | 2 | 76 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.83e-06 | 144 | 38 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 166 | 38 | 4 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-05 | 175 | 38 | 4 | aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-05 | 183 | 38 | 4 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-05 | 183 | 38 | 4 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.99e-05 | 189 | 38 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-05 | 62 | 38 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-05 | 62 | 38 | 3 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 191 | 38 | 4 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 191 | 38 | 4 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 192 | 38 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.21e-05 | 194 | 38 | 4 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| Computational | Genes in the cancer module 367. | 1.95e-05 | 29 | 20 | 3 | MODULE_367 | |
| Computational | Genes in the cancer module 134. | 2.17e-05 | 30 | 20 | 3 | MODULE_134 | |
| Computational | Genes in the cancer module 288. | 4.11e-05 | 37 | 20 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 287. | 1.02e-04 | 50 | 20 | 3 | MODULE_287 | |
| Computational | Genes in the cancer module 27. | 3.93e-04 | 355 | 20 | 5 | MODULE_27 | |
| Computational | Genes in the cancer module 146. | 8.41e-04 | 102 | 20 | 3 | MODULE_146 | |
| Computational | Genes in the cancer module 330. | 1.21e-03 | 28 | 20 | 2 | MODULE_330 | |
| Computational | Membranal receptors. | 2.14e-03 | 517 | 20 | 5 | MODULE_64 | |
| Drug | 2-mercaptoacetate | 2.30e-10 | 7 | 38 | 4 | ctd:C017487 | |
| Drug | Neuropeptide Ff | 1.59e-09 | 69 | 38 | 6 | CID000123797 | |
| Drug | 443C81 | 6.52e-09 | 14 | 38 | 4 | CID000130949 | |
| Drug | AC1L1KRB | 2.94e-08 | 54 | 38 | 5 | CID000005621 | |
| Drug | FdUMP | 6.45e-08 | 63 | 38 | 5 | CID000001816 | |
| Drug | Etorphine | 8.55e-08 | 6 | 38 | 3 | DB01497 | |
| Drug | AC1L2OET | 8.55e-08 | 6 | 38 | 3 | CID000125331 | |
| Drug | NSC612111 | 8.55e-08 | 6 | 38 | 3 | CID000163346 | |
| Drug | RX8008M | 8.55e-08 | 6 | 38 | 3 | CID000162443 | |
| Drug | cyclamate | 1.31e-07 | 28 | 38 | 4 | CID000007533 | |
| Drug | Tyr-ala-phe-gly | 1.49e-07 | 7 | 38 | 3 | CID005487532 | |
| Drug | MET-CAMO | 1.49e-07 | 7 | 38 | 3 | CID006450159 | |
| Drug | phenylmorphan | 1.49e-07 | 7 | 38 | 3 | CID000146306 | |
| Drug | AC1L9PCU | 1.49e-07 | 7 | 38 | 3 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 1.49e-07 | 7 | 38 | 3 | CID005489191 | |
| Drug | beta-naltrexamine | 1.49e-07 | 7 | 38 | 3 | CID005486948 | |
| Drug | NDTMB | 1.49e-07 | 7 | 38 | 3 | CID000134748 | |
| Drug | Kelatorphan | 1.75e-07 | 30 | 38 | 4 | CID000123982 | |
| Drug | AC1N8H7N | 1.90e-07 | 78 | 38 | 5 | CID004318740 | |
| Drug | dl-Bremazocine | 2.01e-07 | 31 | 38 | 4 | CID000001223 | |
| Drug | ICI 204448 | 2.39e-07 | 8 | 38 | 3 | CID000003683 | |
| Drug | metazocine | 2.39e-07 | 8 | 38 | 3 | CID000062518 | |
| Drug | AC1L1B1Q | 2.39e-07 | 8 | 38 | 3 | CID000001246 | |
| Drug | DIPPA | 2.39e-07 | 8 | 38 | 3 | CID000127914 | |
| Drug | 14-methoxymetopon | 2.39e-07 | 8 | 38 | 3 | CID005486940 | |
| Drug | KT-89 | 2.39e-07 | 8 | 38 | 3 | CID005748450 | |
| Drug | binaltorphimine | 2.39e-07 | 8 | 38 | 3 | CID005484197 | |
| Drug | N-methyl nalorphine | 2.39e-07 | 8 | 38 | 3 | CID005748235 | |
| Drug | AC1LBBLW | 2.39e-07 | 8 | 38 | 3 | CID000579851 | |
| Drug | Oxymorphone hydrazone | 2.39e-07 | 8 | 38 | 3 | CID009577748 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 2.39e-07 | 8 | 38 | 3 | CID005492572 | |
| Drug | serotonin | 2.44e-07 | 554 | 38 | 9 | CID000005202 | |
| Drug | Dam K | 3.58e-07 | 9 | 38 | 3 | CID005487344 | |
| Drug | AC1LD4H9 | 3.58e-07 | 9 | 38 | 3 | CID000611919 | |
| Drug | M 285 | 3.58e-07 | 9 | 38 | 3 | CID000020435 | |
| Drug | meptazinol | 3.58e-07 | 9 | 38 | 3 | CID000041049 | |
| Drug | MRZ 2549 | 3.58e-07 | 9 | 38 | 3 | CID000134837 | |
| Drug | Syndyphalin | 3.58e-07 | 9 | 38 | 3 | CID000174117 | |
| Drug | phenylquinone | 3.74e-07 | 36 | 38 | 4 | CID000009688 | |
| Drug | profadol | 5.11e-07 | 10 | 38 | 3 | CID000009882 | |
| Drug | AC1LCF1O | 5.11e-07 | 10 | 38 | 3 | CID000627285 | |
| Drug | normetazocine | 5.11e-07 | 10 | 38 | 3 | CID000001208 | |
| Drug | Naloxone-6-hydrazone | 5.11e-07 | 10 | 38 | 3 | CID009576788 | |
| Drug | beta-FNA | 5.20e-07 | 39 | 38 | 4 | CID005137129 | |
| Drug | Morphiceptin | 5.77e-07 | 40 | 38 | 4 | CID000119303 | |
| Drug | AC1L1I54 | 6.39e-07 | 41 | 38 | 4 | CID000004426 | |
| Drug | PD117302 | 7.01e-07 | 11 | 38 | 3 | CID000122115 | |
| Drug | Trimu-5 | 7.01e-07 | 11 | 38 | 3 | CID005487273 | |
| Drug | Wy-16,225 | 7.01e-07 | 11 | 38 | 3 | CID000040841 | |
| Drug | O-desmethyltramadol | 7.01e-07 | 11 | 38 | 3 | CID000130829 | |
| Drug | AC1LCENG | 7.01e-07 | 11 | 38 | 3 | CID000626667 | |
| Drug | AC1L1I4J | 7.01e-07 | 11 | 38 | 3 | CID000004419 | |
| Drug | methyl (E)-4-[[(4R,4aR,7R,7aR,12bS)-3-(cyclopropylmethyl)-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]amino]-4-oxobut-2-enoate | 7.77e-07 | 43 | 38 | 4 | CID016072169 | |
| Drug | cyclazocine | 9.34e-07 | 12 | 38 | 3 | CID000019143 | |
| Drug | dihydroetorphine | 9.34e-07 | 12 | 38 | 3 | CID000107765 | |
| Drug | AC1L1KS5 | 1.17e-06 | 334 | 38 | 7 | CID000005631 | |
| Drug | 3-(4-chlorophenyl)-N-[3-(cyclopropylmethyl)-9-hydroxy-7-keto-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]acrylamide | 1.21e-06 | 13 | 38 | 3 | CID005149020 | |
| Drug | etonitazene | 1.21e-06 | 13 | 38 | 3 | CID000013493 | |
| Drug | cyprodime hydrobromide | 1.21e-06 | 13 | 38 | 3 | CID005748293 | |
| Drug | methadol | 1.21e-06 | 13 | 38 | 3 | CID000028397 | |
| Drug | quadazocine | 1.54e-06 | 14 | 38 | 3 | CID000115077 | |
| Drug | TDAM | 1.54e-06 | 14 | 38 | 3 | CID000124899 | |
| Drug | TRK-820 | 1.54e-06 | 14 | 38 | 3 | CID006445230 | |
| Drug | naltrindole-5'-isothiocyanate | 1.54e-06 | 14 | 38 | 3 | CID005487327 | |
| Drug | Tdagp | 1.54e-06 | 14 | 38 | 3 | CID005491936 | |
| Drug | 6-.beta.-Naltrexol | 1.54e-06 | 14 | 38 | 3 | CID000631219 | |
| Drug | I06-1317 | 1.54e-06 | 14 | 38 | 3 | CID003081923 | |
| Drug | nalmefene HCl | 1.69e-06 | 52 | 38 | 4 | CID000004422 | |
| Drug | 3-methylfentanyl | 1.92e-06 | 15 | 38 | 3 | CID000061996 | |
| Drug | Ketazocina | 1.92e-06 | 15 | 38 | 3 | CID000071426 | |
| Drug | Fedotozina | 1.92e-06 | 15 | 38 | 3 | CID000060764 | |
| Drug | Tyr-w-mif-1 | 1.92e-06 | 15 | 38 | 3 | CID000132632 | |
| Drug | TIPPpsi | 1.92e-06 | 15 | 38 | 3 | CID005311481 | |
| Drug | E-2078 | 2.37e-06 | 16 | 38 | 3 | CID000122220 | |
| Drug | Dstbulet | 2.37e-06 | 16 | 38 | 3 | CID000130662 | |
| Drug | Dynorphin (1-8) | 2.37e-06 | 16 | 38 | 3 | CID000108135 | |
| Drug | Ici 154129 | 2.37e-06 | 16 | 38 | 3 | CID003035055 | |
| Drug | clonidine | 2.68e-06 | 240 | 38 | 6 | CID000002803 | |
| Drug | 3-dadh-ol | 2.71e-06 | 2 | 38 | 2 | CID000128663 | |
| Drug | Dezocine | 2.71e-06 | 2 | 38 | 2 | DB01209 | |
| Drug | GUM1 compound | 2.71e-06 | 2 | 38 | 2 | ctd:C000611307 | |
| Drug | P 7521 | 2.71e-06 | 2 | 38 | 2 | CID000146384 | |
| Drug | N-propargyl | 2.71e-06 | 2 | 38 | 2 | ctd:C440369 | |
| Drug | N-(3-iodoprop-(2)-enyl) | 2.71e-06 | 2 | 38 | 2 | ctd:C440388 | |
| Drug | methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate | 2.71e-06 | 2 | 38 | 2 | ctd:C533093 | |
| Drug | Cyclazocine | 2.71e-06 | 2 | 38 | 2 | ctd:D003496 | |
| Drug | paynantheine | 2.71e-06 | 2 | 38 | 2 | ctd:C580857 | |
| Drug | dihydroheroin | 2.71e-06 | 2 | 38 | 2 | CID005359460 | |
| Drug | etorphine | 2.81e-06 | 59 | 38 | 4 | CID000026721 | |
| Drug | Tyr-mif-1 | 2.87e-06 | 17 | 38 | 3 | CID000115085 | |
| Drug | fentanyl isothiocyanate | 2.87e-06 | 17 | 38 | 3 | CID000084008 | |
| Drug | Dalce | 2.87e-06 | 17 | 38 | 3 | CID005486712 | |
| Drug | NSC404353 | 3.44e-06 | 18 | 38 | 3 | CID000273032 | |
| Drug | MR 2034 | 3.44e-06 | 18 | 38 | 3 | CID000123980 | |
| Drug | BUBUC | 3.44e-06 | 18 | 38 | 3 | CID006324600 | |
| Drug | ohmefentanyl | 3.44e-06 | 18 | 38 | 3 | CID000062279 | |
| Drug | Buprenorphine | 3.44e-06 | 18 | 38 | 3 | ctd:D002047 | |
| Drug | AC1L1DSH | 4.08e-06 | 19 | 38 | 3 | CID000002487 | |
| Drug | trimebutine | 4.08e-06 | 19 | 38 | 3 | CID000005573 | |
| Drug | Danmme | 4.08e-06 | 19 | 38 | 3 | CID005486529 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.52e-08 | 157 | 36 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Morphine Dependence | 3.03e-05 | 7 | 36 | 2 | C0026552 | |
| Disease | Morphine Abuse | 3.03e-05 | 7 | 36 | 2 | C0600272 | |
| Disease | Cardiac Arrhythmia | 4.27e-04 | 25 | 36 | 2 | C0003811 | |
| Disease | Cocaine Dependence | 6.52e-04 | 139 | 36 | 3 | C0600427 | |
| Disease | Cognition Disorders | 9.90e-04 | 38 | 36 | 2 | C0009241 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 1.39e-03 | 45 | 36 | 2 | EFO_0005671, EFO_0007979 | |
| Disease | Hepatic fibrosis | 1.64e-03 | 49 | 36 | 2 | HP_0001395 | |
| Disease | Withdrawal Symptoms | 2.29e-03 | 58 | 36 | 2 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.29e-03 | 58 | 36 | 2 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.29e-03 | 58 | 36 | 2 | C0038587 | |
| Disease | serum IgE measurement | 2.78e-03 | 64 | 36 | 2 | EFO_0004579 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.96e-03 | 66 | 36 | 2 | DOID:5844 (implicated_via_orthology) | |
| Disease | pentachlorophenol measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022071 | |
| Disease | parathion measurement | 3.60e-03 | 73 | 36 | 2 | EFO_0022070 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKLVVFVSFWQAVVI | 251 | Q9NVA4 | |
| EIVLIWVVSVVLAVP | 221 | P24530 | |
| WSFIVPVTIILISNV | 626 | Q96K78 | |
| IFVLIPVSWTANIII | 131 | P56750 | |
| SNNLWVIVGVVIPVL | 1296 | Q9HCM3 | |
| ISVLVWLIVVVAISP | 171 | P47900 | |
| VVVAVFIVCWTPIHI | 286 | P35372 | |
| IAVAWEVIRTEPIIV | 196 | Q8N3A8 | |
| SLDVWVIAVIVIAIV | 341 | P15529 | |
| VPWEIFLITLVSVVA | 476 | Q5SSG8 | |
| HVRFWVFQIVVISTP | 76 | Q5T442 | |
| FIIPTVATAVWVLIH | 391 | Q96J66 | |
| WIIAAVLAPIAVVTV | 1181 | Q6ZVL6 | |
| DVETQVPQWVITIII | 426 | Q96P66 | |
| ITWITLAVYIVPVIV | 201 | P30559 | |
| PVFPVWVVVGIVTAV | 161 | O95297 | |
| VGVVSVAVAVIPWIA | 851 | O15439 | |
| AQTVLVVVVVFGISW | 246 | P47211 | |
| WIIIAATVVSIIIVF | 141 | Q8NCG7 | |
| VVSWGVPLVITVAAV | 126 | Q5UAW9 | |
| WPLVTFVVGVLIVVL | 176 | Q86W47 | |
| VNFIGLIPVSIWVAV | 476 | O00219 | |
| AVWGIVTLVVLPFAV | 161 | P48145 | |
| VLVVVAVFVVCWTPI | 276 | P41145 | |
| LVVVAVFVGCWTPVQ | 266 | P41146 | |
| PEVVIINSTAVRVIW | 3026 | O75445 | |
| VVIVVVFAVCWLPLH | 281 | P49683 | |
| AVWVASAVVVLPVVV | 166 | P32745 | |
| RVFIAEVPIIAIDWV | 36 | P19387 | |
| SAVWIHPRVNVVIII | 446 | P35523 | |
| EEQILQPWIVVNLVV | 351 | Q96Q45 | |
| QRVVGWVPVLFITFV | 11 | Q5W0Z9 | |
| EVWVVVYTIPAVLTL | 31 | Q6QAJ8 | |
| VFIVVVSVAWLPVVQ | 431 | P31639 | |
| VIVALIGVSVAWIPV | 416 | A0PJK1 | |
| PVLFWVILVLVVVVG | 386 | P28908 | |
| TVVLFVPQQEAWVVE | 36 | Q9UJZ1 | |
| IRWFGVVFVVLVIVL | 76 | Q969W1 |